Navigation Links
China Begins Human Trials For HIV/AIDS Drug

Chinese scientists have announced that they are staring human trials for testing the efficacy of a drug that has proved to be useful for both HIV/AIDS as well as hepatitis B. The chemical, 1,5-di-O-caffeoylquinic acid (1,5-DCQA),// is an extract from a Chinese herb called Inula britannic, has worked on HIV as well as HBV, according to Dong Junxing, a leading scientist with the Academy of Military Medical Sciences.

"If clinical experiments back up initial findings, the compound will be an irreversible HIV and HBV integrase inhibitor, which provides a new alternative for AIDS and hepatitis B treatment," he said on Tuesday. "Preliminary experiments on animals show that suspending, or stopping, the use of the compound during treatment does not lead to deterioration of the disease, which will be a big advance from current anti-HBV and HIV/AIDS medicines, such as the popular cocktail therapy." Professor Dong and his team of reserachers began testing extracts form 100 kinds of Chinese herbs way back in 1993. After successfully extracting useful compounds, they started testing on monkeys and ducks. "Half of the monkeys were recuperating; and the other half continued in a stable condition with our treatment," Dong said of his animal experiments. They have now begun testing on 200 healthy human volunteers, "If it goes smoothly, a new medicine will be on the market in two years," he said. "We will try a combined prescription of the new drug and current medicines to see whether it can have better efficacy."
'"/>




Page: 1

Related medicine news :

1. China tells officials not to hide SARS damage
2. China reports declining number of SARS Cases
3. China says patient may have SARS
4. 15 Anti-SARS Drugs Identified By China-Europe Team of Researchers
5. Adverse Effects Associated with Unauthorised Hepatitis A Vaccine in China
6. Pig Bacterium (Streptococcus suis) Kills 24 In China
7. Watch Out! Pollution hazard from E-waste recycling in India & China
8. French Fries In Cancer Controversy In China
9. China To Distribute Free Condoms To Combat AIDS/HIV
10. HIV Cases Steadily Increasing In China With The Toll Over 1.26 Lakh
11. India And China Discuss Import Of Encephalitis Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/21/2017)... ... 21, 2017 , ... Salveo for life, a company that distributes an effervescent ... United States as part of its presence to expand its market reach. , Using ... the productions of nasty toxins as a result of drinking alcohol, eliminating those toxins ...
(Date:1/21/2017)... ... 21, 2017 , ... Northern California Medical Associates (NCMA) is ... multi-specialty medical group. The dermatology practice provides general dermatologic treatment, outpatient surgery, clinical ... this excellent dermatology practice to our group’s medical services,” explains NCMA CEO, Ruth ...
(Date:1/20/2017)... ... ... A new partnership between Goodwill® and Roadie, Inc. aims to make it easier ... couches to dressers and bicycles. Roadie — the national on-the-way delivery network — will ... through February 28th. , “January is an exciting time when resolutions are made ...
(Date:1/20/2017)... ... , ... Lice Troopers, the lice removal company based in South Florida, has ... holiday season. , “It happens every year around this time,” says owner, Arie ... which is the head-to-head gateway that lice need to spread.” , As children return ...
(Date:1/20/2017)... ... January 20, 2017 , ... Vitamin Well ... VW+ 002. The drinks have been produced in collaboration with Zlatan Ibrahimovic and ... your workout. , After a successful launch in Sweden last year, the next ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017 Conference Call and Webcast ... VNDA ) today announced it will release results for the fourth ... closes. ... will host a conference call at 4:30 PM ET on Wednesday, ... and full year 2016 financial results and other corporate activities. To ...
(Date:1/19/2017)... LONDON , January 19, 2017 Incretin ... Sympathomimetics and Others The global anti-obesity drugs ... the first half of the forecast period and CAGR of 38.7% ... expected to grow at a CAGR of 32.8% from 2016 to ... million in 2021, and $24,063 million in 2027. ...
(Date:1/19/2017)... BOCA RATON, Fla. , Jan. 19, 2017 ... ), a medical device company specializing in the ... conditions, such as keloids, with superficial radiation therapy, ... quarter and full year 2016 financial results on Thursday, ... The Company will hold a conference call ...
Breaking Medicine Technology: